PT87454A - Heterocyclic ketones - Google Patents

Heterocyclic ketones

Info

Publication number
PT87454A
PT87454A PT87454A PT8745488A PT87454A PT 87454 A PT87454 A PT 87454A PT 87454 A PT87454 A PT 87454A PT 8745488 A PT8745488 A PT 8745488A PT 87454 A PT87454 A PT 87454A
Authority
PT
Portugal
Prior art keywords
formula
compounds
heterocyclic ketones
pharmaceutically acceptable
acceptable base
Prior art date
Application number
PT87454A
Other languages
English (en)
Other versions
PT87454B (pt
Inventor
Philip Duke Edwards
Joseph James Lewis
Charles William Perkins
Diane Amy Trainor
Richard Alan Wildonger
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878711050A external-priority patent/GB8711050D0/en
Priority claimed from GB888803206A external-priority patent/GB8803206D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of PT87454A publication Critical patent/PT87454A/pt
Publication of PT87454B publication Critical patent/PT87454B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT87454A 1987-05-11 1988-05-11 Processo para a preparacao de cetonas heterociclicas PT87454B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878711050A GB8711050D0 (en) 1987-05-11 1987-05-11 Selected heterocyclic ketones
GB888803206A GB8803206D0 (en) 1988-02-11 1988-02-11 Selected heterocyclic ketones

Publications (2)

Publication Number Publication Date
PT87454A true PT87454A (pt) 1989-05-31
PT87454B PT87454B (pt) 1992-08-31

Family

ID=26292230

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87454A PT87454B (pt) 1987-05-11 1988-05-11 Processo para a preparacao de cetonas heterociclicas

Country Status (22)

Country Link
US (1) US5164371A (pt)
EP (1) EP0291234B1 (pt)
JP (1) JPS6445395A (pt)
KR (1) KR880013926A (pt)
CN (1) CN1037519A (pt)
AT (1) ATE103293T1 (pt)
AU (1) AU605284B2 (pt)
CA (1) CA1326107C (pt)
DE (1) DE3888568T2 (pt)
DK (1) DK260588A (pt)
ES (1) ES2063034T3 (pt)
FI (1) FI91072C (pt)
GB (1) GB8809316D0 (pt)
HU (1) HU201963B (pt)
IE (1) IE62524B1 (pt)
IL (1) IL86236A (pt)
NO (1) NO176519C (pt)
NZ (1) NZ224452A (pt)
PT (1) PT87454B (pt)
SU (1) SU1678207A3 (pt)
ZA (1) ZA883006B (pt)
ZW (1) ZW4988A1 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910550D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted amides
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
DE69131058T2 (de) * 1990-05-24 1999-09-09 Zeneca Ltd Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
EP0458536B1 (en) * 1990-05-24 1998-03-18 Zeneca Limited Therapeutic agent for treatment and prevention of adult respiratory distress syndrome
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
CA2049100A1 (en) * 1990-09-10 1992-03-11 Hirohiko Yamada Benzoic acid phenylester compounds and elastase inhibiting compositions containing the same
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US20020119985A1 (en) * 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US5556990A (en) * 1994-12-16 1996-09-17 Rhone-Poulenc Rorer Pharmaceuticals Inc. Polyarylcarbamoylaza- and -carbamoylalkanedioic acids
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5872101A (en) * 1995-01-06 1999-02-16 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
AU6896398A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
AU741099B2 (en) * 1997-04-14 2001-11-22 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
CA2285685A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
US6274602B1 (en) * 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6177572B1 (en) 1997-08-20 2001-01-23 Sepracor, Inc. Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
US6184377B1 (en) 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
JP2003535022A (ja) * 1998-06-03 2003-11-25 コーテック インコーポレーテッド セリンプロテアーゼ阻害剤としてのアルファー‐ケトオキサジアゾール含有ペプトイド及び非ペプトイド
JP2000256396A (ja) 1999-03-03 2000-09-19 Dainippon Pharmaceut Co Ltd 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
TW200404789A (en) 1999-03-15 2004-04-01 Axys Pharm Inc Novel compounds and compositions as protease inhibitors
WO2000056724A1 (en) * 1999-03-22 2000-09-28 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Oxazole and thiazole combinatorial libraries
JP2003502442A (ja) * 1999-06-17 2003-01-21 ソース・プリシジョン・メディシン・インク セリンエラスターゼの活性を阻害する方法及び化合物
JP2004523506A (ja) 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
KR20040044920A (ko) 2001-09-14 2004-05-31 아벤티스 파마슈티칼스 인크. 카뎁신 억제제로서 신규한 화합물 및 조성물
KR20050044497A (ko) 2001-11-14 2005-05-12 아벤티스 파마슈티칼스 인크. 올리고펩티드 및 카텝신 ｓ 억제제로서 이를 포함하는조성물
AU2003231016A1 (en) * 2002-04-16 2003-10-27 Aventis Pharmaceuticals, Inc., Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
JP3744890B2 (ja) 2002-11-01 2006-02-15 ハッピー工業株式会社 ミシン
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
AU2007253819B2 (en) 2006-05-23 2011-02-17 Irm Llc Compounds and compositions as channel activating protease inhibitors
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
EP2117537A1 (en) 2007-02-09 2009-11-18 Irm Llc Compounds and compositions as channel activating protease inhibitors
FR2914920B1 (fr) 2007-04-11 2011-09-09 Clariant Specialty Fine Chem F Procede de deacetalisation d'alpha-aminoacetals.
FR2916441B1 (fr) 2007-05-22 2009-08-28 Clariant Specialty Fine Chem Procede de racemisation d'alpha-aminoacetals optiquement actifs.
US20100273835A1 (en) * 2007-07-10 2010-10-28 Probiodrug Ag Novel compounds
US20090156509A1 (en) * 2007-12-12 2009-06-18 Accuthera, Inc. Tri-peptide Inhibitors of Serine Elastases
FR2927900B1 (fr) 2008-02-27 2010-09-17 Clariant Specialty Fine Chem Procede de preparation d'alpha-aminoacetals optiquement actifs.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3481913D1 (de) * 1983-04-27 1990-05-17 Ici America Inc Prolin-derivate.
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0204571B1 (en) * 1985-06-07 1992-01-22 Ici Americas Inc. Selected difluoro derivatives
JPH03505210A (ja) * 1988-09-09 1991-11-14 ユニバーシティー オブ ケンタッキー リサーチ ファウンデーション エラスターゼ阻害ポリマーおよび方法
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones

Also Published As

Publication number Publication date
NO882036L (no) 1988-11-14
DE3888568D1 (de) 1994-04-28
FI91072C (fi) 1994-05-10
IE62524B1 (en) 1995-02-08
ZA883006B (pt) 1988-11-11
FI882176A0 (fi) 1988-05-10
NZ224452A (en) 1991-06-25
SU1678207A3 (ru) 1991-09-15
HU201963B (en) 1991-01-28
NO176519C (no) 1995-04-19
NO882036D0 (no) 1988-05-10
PT87454B (pt) 1992-08-31
FI882176A (fi) 1988-11-12
FI91072B (fi) 1994-01-31
AU605284B2 (en) 1991-01-10
CN1037519A (zh) 1989-11-29
DK260588D0 (da) 1988-05-11
CA1326107C (en) 1994-01-11
NO176519B (no) 1995-01-09
ATE103293T1 (de) 1994-04-15
IE881416L (en) 1988-11-11
KR880013926A (ko) 1988-12-22
IL86236A0 (en) 1988-11-15
EP0291234A3 (en) 1990-08-22
IL86236A (en) 1994-12-29
AU1539088A (en) 1988-11-17
EP0291234B1 (en) 1994-03-23
GB8809316D0 (en) 1988-05-25
HUT46708A (en) 1988-11-28
DK260588A (da) 1988-11-12
JPS6445395A (en) 1989-02-17
ES2063034T3 (es) 1995-01-01
ZW4988A1 (en) 1989-12-06
US5164371A (en) 1992-11-17
DE3888568T2 (de) 1994-07-21
EP0291234A2 (en) 1988-11-17

Similar Documents

Publication Publication Date Title
PT87454A (pt) Heterocyclic ketones
DE69232022D1 (de) Naphthyridinderivate als Angiotensin-II-Antagonist-Inhibitoren
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
EP0276101A3 (en) Substituted peptide derivatives
DE69332366D1 (de) Arylsubstituierte heterocyclische Verbindungen
DE69329184T2 (de) Alkylsubstituierte heterocyclische Verbindungen
ATE116974T1 (de) 5- piperazinylalkyl-1,5-benzothiazepinone verwendbar als calciumantagonisten.
DK23089D0 (da) Thioformamidderivater og deres anvendelse
DE69208384T2 (de) Fungizide Furanonderivate

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920214

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970831